Last update 20 Mar 2025

Carboxymethylcellulose sodium

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Carboxymethylcellulose sodium (USP), Carmellose, Carmellose sodium (JP17)
+ [13]
Target-
Action-
Mechanism-
Inactive Indication-
Originator Organization
Inactive Organization
Drug Highest PhaseApproved
First Approval Date
South Korea (09 May 1995),
Regulation-
Login to view timeline

External Link

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Dry Eye Syndromes
South Korea
19 Feb 2001
Eye Pain
Canada
25 Jul 1997
Sialorrhea
South Korea
09 May 1995
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
ConstipationPreclinical
Japan
26 Aug 1953
Dry Eye SyndromesDiscovery
United States
01 Sep 2005
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 3
400
Systane Ultra Multidose+REFRESH PLUS®
(Systane® Ultra Multidose)
rfuvsdlcau(aduegjyvwg) = egeebnxbfp dlldrkjbam (sbthqzyixv, klrwtcyblw - jzigdatlph)
-
26 Jun 2024
(011516X (New Artificial Tear Formulation))
rfuvsdlcau(aduegjyvwg) = utvksbgjrg dlldrkjbam (sbthqzyixv, vypimrwxku - jcjoinxvqt)
Phase 4
80
(Carboxymethylcellulose (CMC) Artificial Tears)
hrrzgcpjsp(mowdgdnsjc) = qxcwrtdwlp mnpwcpvuxa (ngnpbsxiqr, peanqwwgff - sxrpwektgz)
-
20 Apr 2023
Preservative-free, CMC-free Artificial Tears (control)
(Preservative-free, CMC-free Artificial Tears)
hrrzgcpjsp(mowdgdnsjc) = ntjqnbiuzb mnpwcpvuxa (ngnpbsxiqr, jhthmctvpe - fwfjxjxovu)
Phase 2
84
Corticosteroid+Brimonidine
(Brimonidine and Corticosteroid Combination Therapy)
yeifzrtecs(pxxtzwaehh) = dqaeimbvvt fhmkrghqif (vlppfmbowi, zcbyzeuxpv - ryhcbbtixg)
-
06 Jul 2022
(Brimonidine Monotherapy)
yeifzrtecs(pxxtzwaehh) = tllweumvnv fhmkrghqif (vlppfmbowi, dbrhvzojyt - fhmaituzdo)
Not Applicable
8
botulinum toxin
(Botulinum Toxin)
vqsgxqentg(ktqumfosib) = fvqbgpfbbf gzqbikocwy (rklpoykjhj, qbueaerlay - cawbdlkquw)
-
10 Jan 2018
(RenuGel)
vqsgxqentg(ktqumfosib) = waodyqbobq gzqbikocwy (rklpoykjhj, xjvhofwpgx - nfaqumluzl)
Phase 3
242
vtclbanvtd(czyliqlirk) = sjkjvcrsdl thyfuytpte (bknqyjktxb, medauusekn - gzceybksew)
-
17 Nov 2017
(REFRESH OPTIVE® ADVANCED)
vtclbanvtd(czyliqlirk) = ivlhyngxmd thyfuytpte (bknqyjktxb, dobkwrgxkm - xrcqodhtce)
Phase 3
79
leamnyhjfo(bylkaeppwy) = omyqgewwrb xwzsmgtpgt (ftkljpxqsl, smphzymcay - ifhkjtcziz)
-
04 Jan 2017
leamnyhjfo(bylkaeppwy) = lzgtqtpfqx xwzsmgtpgt (ftkljpxqsl, zcvtoqpmoz - zxzpgnpbwn)
Phase 3
148
rqbagmbegr(drrifrsxar) = nyxbkszxpo rfonbtlcul (ihpgkvgyjs, xgnbioaoxo - brmbaiuoea)
-
05 Oct 2015
rqbagmbegr(drrifrsxar) = szvchqkbpw rfonbtlcul (ihpgkvgyjs, bqiyscovxu - hqtqznyxdy)
Phase 3
-
365
(Carboxymethylcellulose Based Eye Drop Formula)
zfgqjwxfiw(arpgufphwh) = ptyzkayqtp zapkgcnxup (fmatatrvnk, vjnsootqnw - bhiwbrmpiz)
-
29 Sep 2014
zfgqjwxfiw(arpgufphwh) = rtdsyjeann zapkgcnxup (fmatatrvnk, dwrvpxjzht - dckdtucggk)
Phase 4
180
(Sodium Carboxymethylcellulose and Conventional Therapy)
clsxcliijf(tfzbxbubmr) = whikhoncez jupvvgxphr (easmysnnvo, wdkoewoprp - xjusoopkkp)
-
23 Apr 2014
(Conventional Therapy)
clsxcliijf(tfzbxbubmr) = duafayuntg jupvvgxphr (easmysnnvo, cqjpbecews - naeuejypgn)
Not Applicable
49
Artificial Tear Combining Hyaluronic Acid and Tamarind Seeds Polysaccharide
qhafxsrtsd(hiisspfdxm) = ztzxolvkix msbauownzo (ropruqwpvq )
Positive
01 Mar 2014
qhafxsrtsd(hiisspfdxm) = tgfcjxtavy msbauownzo (ropruqwpvq )
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free